Quanterix Corporation (QTRX)
Bid | 6.62 |
Market Cap | 258.77M |
Revenue (ttm) | 135.29M |
Net Income (ttm) | -49.96M |
EPS (ttm) | -1.24 |
PE Ratio (ttm) | -5.37 |
Forward PE | -6.13 |
Analyst | Buy |
Ask | 6.8 |
Volume | 1,048,111 |
Avg. Volume (20D) | 784,398 |
Open | 6.69 |
Previous Close | 6.57 |
Day's Range | 6.43 - 6.85 |
52-Week Range | 4.05 - 16.74 |
Beta | 1.05 |
About QTRX
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for QTRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
3 weeks ago · businesswire.com
Quanterix to Present at Goldman Sachs Global Healthcare ConferenceBILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Exe...

1 month ago · businesswire.com
Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conferen...

1 month ago · businesswire.com
Quanterix and Akoya Biosciences Announce Amended Merger AgreementBILLERICA, Mass. & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences ...